Inhaled Nitric Oxide Market Outlook
The global inhaled nitric oxide market size was valued at USD 800.0 million in 2023, driven by the rising emphasis on neonatal care across the globe. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to achieve a value of USD 1,612.6 million by 2032.
Inhaled Nitric Oxide: Introduction
Inhaled Nitric Oxide (iNO) is a medical treatment involving the inhalation of nitric oxide gas. It is primarily used to improve oxygenation in patients with certain respiratory conditions, such as newborns with persistent pulmonary hypertension or adults with acute respiratory distress syndrome (ARDS). Nitric oxide is a potent vasodilator, meaning it relaxes and widens blood vessels in the lungs, increasing blood flow to areas with reduced oxygen levels. This helps to optimize oxygen exchange in the lungs, improving oxygenation and reducing strain on the heart. Inhaled Nitric Oxide is administered in controlled medical settings and can be a life-saving intervention for individuals with severe respiratory issues.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/inhaled-nitric-oxide-market/requestsample
Key Trends in the Inhaled Nitric Oxide Market
The application of inhaled nitric oxide has been a significant advancement in the care of critically ill neonates. While the primary application for iNO has been in neonates, there’s growing interest and research into its potential benefits for adults and children with acute respiratory distress syndrome (ARDS) and other pulmonary complications.
Earlier iNO delivery systems were large and not easy to transport. However, technological advancements have led to the development of smaller, portable systems. This portability has allowed for expanded use of iNO beyond just hospital settings. As patents expire, the market has seen the introduction of generic versions of inhaled nitric oxide. This competition may lead to more affordable treatment options and expand patient access.
Given the critical nature of the patient populations receiving iNO, there’s a heightened focus on ensuring the quality, safety, and efficacy of these products. This scrutiny means rigorous testing, approvals, and post-market surveillance. With the outbreak of the COVID-19 pandemic, there has been research into the potential benefits of iNO for patients with severe respiratory complications from the virus. Some studies suggest that iNO might have antiviral effects against SARS-CoV-2, leading to a possible role in both treating and preventing COVID-19, although further research is required.
Given the potential risks and benefits of iNO, there’s a growing emphasis on educating healthcare professionals on its appropriate use. This education helps ensure that iNO is administered correctly, maximizing benefits and minimizing risks. In some regions, the high cost of iNO therapy can be a limiting factor for its widespread adoption. Efforts are being made to address these challenges, ensuring that more patients can access this potentially life-saving treatment.
Companies in the iNO market are forming collaborations and partnerships to enhance research, expand their product portfolios, and reach a wider customer base. This collaboration often brings together expertise from different areas, promoting innovation and market growth.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/inhaled-nitric-oxide-market
Inhaled Nitric Oxide Market Segmentation
Market Breakup by Strength
• 100 ppm
• 800 ppm
• Others
Market Breakup by Purity
• 99.92% Purity
• 99.99% Purity
• Others
Market Breakup by Applications
• Chronic Obstructive Pulmonary Disease (COPD)
• Neonatal Respiratory Treatment
• Tuberculosis Treatment
• Acute Respiratory Distress Syndrome (ARDS)
• Malaria Treatment
• Others
Market Breakup by End User
• Clinics
• Hospitals
• Others
Market Breakup by Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
Market Breakup by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Inhaled Nitric Oxide Market Overview
North America leads in the consumption of inhaled nitric oxide due to its robust healthcare infrastructure, high awareness levels, and well-established neonatal intensive care practices. Additionally, the presence of key market players in the region boosts market growth. The U.S. has witnessed an increased focus on research related to iNO applications, including its potential use in treating COVID-19 respiratory complications. Insurance coverage and reimbursement policies also play a significant role in the adoption of iNO therapies.
Europe holds a significant share in the global iNO market, driven by advanced healthcare systems, strong R&D activities, and a focus on neonatal care. Regulatory bodies such as the European Medicines Agency (EMA) closely monitor iNO products for safety and efficacy. Additionally, European nations are collaborating on research projects to study broader applications of iNO.
Asia-Pacific (APAC) region is expected to witness rapid growth in the coming years due to rising awareness about neonatal care, increasing healthcare expenditure, and a growing middle-class population. While countries like Japan and Australia have well-established neonatal care systems, emerging markets like China and India present substantial growth opportunities. However, the high cost of iNO therapy might be a limiting factor in some of these countries.
Inhaled Nitric Oxide Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
• Mallinckrodt
• Linde plc.
• Air Liquide
• BOC Limited
• Bellerophon Therapeutics
• Beyond Air Inc.
• Halma plc.
• VERO Biotech
• Nu-Med Plus
• Getinge AB
• Merck KGaA
• Genosys Informatics
• Geno
• Perma Pure LLC
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Jhon Roy, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
